News & Updates

Show Multimedia Only
Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

17 Aug 2026 byNatalia Reoutova

A retrospective cohort study conducted in Hong Kong among adults with co-existing asthma and diabetes mellitus (DM) has found a lower risk of asthma exacerbation with glucagon-like peptide-1 receptor agonist (GLP-1 RA) vs dipeptidyl peptidase-4 inhibitor (DPP-4i) treatment.

17 Aug 2026
Comorbidities prevalent in patients with RA

Comorbidities prevalent in patients with RA

14 Aug 2026 byStephen Padilla

Patients with rheumatoid arthritis (RA) also suffer several comorbidities, the most common being circulatory and metabolic disorders, according to a Bangladesh study.

14 Aug 2026